Patents by Inventor Susan Grant

Susan Grant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200129327
    Abstract: The present invention relates to a medical device for treating, preventing or ameliorating an eye condition. The device comprises a cover, at least a portion of which comprises an antimicrobial agent and is at least partially filled with temperature control means. In use, the cover is arranged to contact a subject's eye and/or a surrounding area thereof, and the temperature control means is configured to modulate the temperature of the cover to thereby treat, prevent or ameliorate the eye condition.
    Type: Application
    Filed: April 19, 2018
    Publication date: April 30, 2020
    Inventors: Susan Grant, Adam Wymer, Sam Wymer
  • Publication number: 20140315272
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP2, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: April 21, 2014
    Publication date: October 23, 2014
    Applicant: DANISCO US INC.
    Inventors: BRIAN E. JONES, WILLIAM D. GRANT, SHAUN HEAPHY, SUSAN GRANT, HELEN REES
  • Patent number: 8753852
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP1, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: June 17, 2014
    Assignee: Danisco US Inc.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Patent number: 8742071
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP2, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: June 3, 2014
    Assignee: Danisco US Inc.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Patent number: 8329440
    Abstract: The present invention provides a novel nucleic acid sequence, designated ELIP, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: December 11, 2012
    Assignee: Danisco US Inc.
    Inventors: Brian E Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen C. Rees
  • Publication number: 20120107906
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP1, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 3, 2012
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Patent number: 8158397
    Abstract: The present invention provides a novel cellulase nucleic acid sequence, designated 029cel, and the corresponding 029cel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding 029cel, recombinant 029cel proteins and methods for producing the same.
    Type: Grant
    Filed: August 18, 2009
    Date of Patent: April 17, 2012
    Assignee: Danisco US Inc.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant
  • Publication number: 20120052545
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP2, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: March 11, 2010
    Publication date: March 1, 2012
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Publication number: 20110312028
    Abstract: The present invention provides a novel nucleic acid sequence, designated ELIP, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: May 24, 2010
    Publication date: December 22, 2011
    Inventors: BRIAN E. JONES, WILLIAM D. GRANT, SHAUN HEAPHY, SUSAN GRANT
  • Publication number: 20110281325
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP1, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: October 15, 2010
    Publication date: November 17, 2011
    Applicant: DANISCO US, INC.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Patent number: 7892807
    Abstract: The present invention provides a novel cellulase nucleic acid sequence, designated BagCel, and the corresponding BagCel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BagCel, recombinant BagCel proteins and methods for producing the same.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: February 22, 2011
    Assignee: Danisco US Inc.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant
  • Patent number: 7833773
    Abstract: The present invention provides a novel cellulase nucleic acid sequence, designated mHKcel, and the corresponding mHKcel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding mHKcel, recombinant mHKcel proteins and methods for producing the same.
    Type: Grant
    Filed: October 6, 2008
    Date of Patent: November 16, 2010
    Assignee: Danisco US Inc.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Publication number: 20100227364
    Abstract: The present invention provides a novel nucleic acid sequence, designated ELIP, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: May 24, 2010
    Publication date: September 9, 2010
    Inventors: BRIAN E. JONES, WILLIAM D. GRANT, SHAUN HEAPHY, SUSAN GRANT
  • Patent number: 7754468
    Abstract: The present invention provides a novel nucleic acid sequence, designated ELIP, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: July 13, 2010
    Assignee: Danisco US Inc.
    Inventors: Brian E Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen C. Rees
  • Publication number: 20100167375
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP2, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: March 11, 2010
    Publication date: July 1, 2010
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Publication number: 20100129862
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP1, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: May 12, 2004
    Publication date: May 27, 2010
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Publication number: 20100048417
    Abstract: The present invention provides a novel cellulase nucleic acid sequence, designated 029cel, and the corresponding 029cel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding 029cel, recombinant 029cel proteins and methods for producing the same.
    Type: Application
    Filed: August 18, 2009
    Publication date: February 25, 2010
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant
  • Publication number: 20090269805
    Abstract: The present invention provides a novel nucleic acid sequence, designated ELIP, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: February 27, 2009
    Publication date: October 29, 2009
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant
  • Patent number: 7604974
    Abstract: The present invention provides a novel cellulase nucleic acid sequence, designated 029cel, and the corresponding 029cel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding 029cel, recombinant 029cel proteins and methods for producing the same.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: October 20, 2009
    Assignee: Genencor International, Inc.
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant
  • Publication number: 20090098602
    Abstract: The present invention provides a novel cellulase nucleic acid sequence, designated mHKcel, and the corresponding mHKcel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding mHKcel, recombinant mHKcel proteins and methods for producing the same.
    Type: Application
    Filed: October 6, 2008
    Publication date: April 16, 2009
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees